Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 114899-77-3 Chemical Structure| 114899-77-3

Structure of Trabectedin
CAS No.: 114899-77-3

Chemical Structure| 114899-77-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Trabectedin is an antitumour agent of marine origin with potent antitumour activity both in vitro and in vivo.

Synonyms: Ecteinascidin 743; ET-743; NSC 648766

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Trabectedin

CAS No. :114899-77-3
Formula : C39H43N3O11S
M.W : 761.84
SMILES Code : O[C@@H]([C@@]1([H])N(C)[C@]2([H])C3=C(C=C(C)C(OC)=C3O)C1)N4[C@@]2([H])[C@@](SC[C@@]5(NCC6)C7=C6C=C(O)C(OC)=C7)([H])C8=C(C(OCO9)=C9C(C)=C8OC(C)=O)[C@]4([H])COC5=O
Synonyms :
Ecteinascidin 743; ET-743; NSC 648766
MDL No. :MFCD00874849

Safety of Trabectedin

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H300-H312-H332-H341-H361-H373
Precautionary Statements:P261-P281-P301+P310-P305+P351+P338
Class:6.1
UN#:2811
Packing Group:

Isoform Comparison

Biological Activity

Description
Trabectedin (Ecteinascidin 743; ET-743) is a tetrahydroisoquinoline alkaloid known for its potent antitumor activity. It functions by binding to the minor groove of DNA, blocking the transcription of stress-induced proteins, inducing DNA backbone cleavage, promoting apoptosis in cancer cells, and increasing the production of reactive oxygen species (ROS) in MCF-7 and MDA-MB-453 cells. Trabectedin is being studied for its potential applications in treating soft tissue sarcoma and ovarian cancer[1][2][3].

In Vitro:

Cell Line
Concentration Treated Time Description References
IB134 1.92 nM 72 hours Evaluate the antiproliferative effect of Trabectedin PMC5387279
93T449 0.869 nM 72 hours Evaluate the antiproliferative effect of Trabectedin PMC5387279
IB128 0.546 nM 72 hours Evaluate the antiproliferative effect of Trabectedin PMC5387279
IB112 0.984 nM 72 hours Evaluate the antiproliferative effect of Trabectedin PMC5387279
IB114 0.352 nM 72 hours Evaluate the antiproliferative effect of Trabectedin PMC5387279
IB136 1.1 nM 72 hours Evaluate the antiproliferative effect of Trabectedin PMC5387279
IB133 2.64 nM 72 hours Evaluate the antiproliferative effect of Trabectedin PMC5387279
IB111 0.480 nM 72 hours Evaluate the antiproliferative effect of Trabectedin PMC5387279
IB115 0.445 nM 72 hours Evaluate the antiproliferative effect of Trabectedin PMC5387279
MSCs (mesenchymal stem cells) 1 nM 21 days To evaluate the effect of ET-743 and RSG on MSC differentiation. ET-743 alone induced CEBPα expression, while the combination of ET-743 and RSG induced both PPARγ and CEBPα expression, promoting adipocytic differentiation. PMC3287226
TC32 cells 5 nmol/L 6 hours Lurbinectedin redistributed EWS-FLI1 to the nucleolus to the same degree as trabectedin PMC5567825
SJSA-1 cells 0.125 nM 24 hours To evaluate the synergistic effect of trabectedin and olaparib combination, results showed no significant enhancement of DNA damage and apoptosis PMC5410089
DMR cells 0.125 nM 24 hours To evaluate the synergistic effect of trabectedin and olaparib combination, results showed significant enhancement of DNA damage and apoptosis PMC5410089
T-47D 5 × 10⁻⁶ M 96 hours To evaluate the inhibitory effect of trabectedin in combination with metformin and CB-2 on breast cancer cell proliferation PMC8867195
MDA-MB-231 5 × 10⁻⁶ M 96 hours To evaluate the inhibitory effect of trabectedin in combination with metformin and CB-2 on breast cancer cell proliferation PMC8867195
MCF-7 5 × 10⁻⁶ M 96 hours To evaluate the inhibitory effect of trabectedin in combination with metformin and CB-2 on breast cancer cell proliferation PMC8867195
TC32 cells 5 nmol/L 6 hours Trabectedin caused EWS-FLI1 to redistribute within the nucleus and co-localize with the nucleolus marker nucleolin PMC5567825

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mouse PTCp53null mouse model Tail vein injection 0.05 mg/kg Every 4 days To evaluate the effect of ET-743 alone or in combination with RSG on the MRCLS mouse model. ET-743 significantly prolonged survival and promoted adipocytic differentiation, and RSG enhanced the effect of ET-743. PMC3287226
Rag γ2C-/- mice IB115 cell xenograft model Intravenous injection 0.05 mg/kg Once a week for 3 weeks Evaluate the antitumor effect of Trabectedin PMC5387279
NOD/SCID mice Subcutaneous and orthotopic tumor xenografts Intravenous and intraperitoneal injection 0.05 mg/kg Weekly trabectedin and daily olaparib for 21 days To evaluate the antitumor activity of trabectedin and olaparib combination, results showed significant inhibition of tumor growth and metastasis PMC5410089
Nude mice MCF-7 xenograft model Intraperitoneal injection 0.2 mg/kg Once every two days for 4 weeks To evaluate the inhibitory effect of trabectedin in combination with metformin and CB-2 on diabetes-associated breast cancer PMC8867195
Balb/c nude mice Subcutaneous transplantation of mouse CDS tumor model Intravenously 100 mg/kg/day Three times for every four days, total 300 mg/kg To test the growth inhibitory effect of trabectedin on mouse CDS tumors, results showed significant tumor growth suppression. PMC5488331
Mice HU-HSC-NPG.GM3 humanized immune system mouse model Intravenous injection 0.15 mg/kg/per mouse Once a week The combination of shTRAIL and trabectedin could remodel the tumor immune microenvironment, further enhance antitumor immunity, and strikingly improve antitumor effects. PMC10464183
Mice APL and MLL-AF9 AML models Intravenous injection 0.2 mg/kg Single or multiple injections Trabectedin inhibits leukemic progression by depleting inflammatory monocytes (IMs) and synergizes with chemotherapy and PD-1 blockade to significantly prolong the survival of AML mice. PMC8500518
CD1 nude mice MLPS patient-derived xenograft (PDX) models Subcutaneous injection 0.15 mg/kg Every 7 days for three times To study the effect of Trabectedin on FUS-DDIT3 binding activity and evaluate its efficacy in sensitive and resistant models PMC11590625

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01692496 Advanced and / or Metastatic L... More >>iposarcoma Less << Phase 2 Completed - Germany ... More >> HELIOS Klinikum Berlin-Buch (Sarkomzentrum Berlin-Brandenburg) Berlin, Germany, D-10707 Universitätsklinikum EssenInnere Klinik (Tumorforschung) Essen, Germany, D-45147 Medizinische Hochschule Hannover (Zentrum Innere Medizin) Hannover, Germany, D-30625 Universitätsmedizin Mannheim (Sarkomzentrum) Manheim, Germany, D-68169 Klinikum Großhadern der LMU Universität München (Med. Klinik und Poliklinik II) Munich, Germany, D-80336 Spain Hospital Central de Asturias Oviedo, Asturias, Spain, 33011 Hospital Universitario de Canarias La Laguna, Islas Canarias, Spain, 38320 Hospital de Navarra Pamplona, Navarra, Spain, 31008 Complejo Hospitalario Universitario de Vigo Vigo, Pontevedra, Spain, 36204 Hospital Vall d'Hebrón Barcelona, Spain, 08035 Hospital 12 de Octubre Madrid, Spain, 28041 Hospital Universitari Son Espases Palma de Mallorca, Spain, 07010 Hospital Universitario Virgen del Rocío Sevilla, Spain, 41013 Instituto Valenciano de Oncología Valencia, Spain, 46009 Hospital Miguel Servet Zaragoza, Spain, 50009 Less <<
NCT03056599 Soft Tissue Sarcoma Adult Phase 1 Recruiting December 31, 2019 United States, New York ... More >> Monter Cancer Center (Northwell Health) Recruiting Lake Success, New York, United States, 11042 Contact: Sharon Fox          Principal Investigator: Gary Deutsch, MPH, MD          Sub-Investigator: Robert Maki, MD, PHD          Sub-Investigator: Tony Philip, MD          Sub-Investigator: Mee-young Lee, NP          Sub-Investigator: Shamsah Lakhani, PA          Sub-Investigator: Priscila Goncalves, MD          Sub-Investigator: Eran Ben-Levi, MD          Sub-Investigator: Daniel Ramirez, MD          Sub-Investigator: Brian Burke, MD          Sub-Investigator: Howard Goodman, MD          United States, Oregon OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Sierra Bertolone-Smith          Principal Investigator: Kenneth Gundle, MD          United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States, 98109 Contact: Taylor Hain          Principal Investigator: Seth Pollack, MD          University of Washington Recruiting Seattle, Washington, United States, 98195 Contact: Taylor Hain          Sub-Investigator: Darin Davidson, MD          Sub-Investigator: Matthew Thompson, MD Less <<
NCT01710176 Localized High-risk Soft Tissu... More >>e Sarcomas of the Extremities and Trunk Wall in Adults Less << Phase 3 Recruiting January 2021 Italy ... More >> Irccs Centro Di Riferimento Oncologico (Cro) - Recruiting Aviano (pn), Italy Irccs Istituto Ortopedico Rizzoli (Ior) - Recruiting Bologna (BO), Italy Pres.Ospedal.Spedali Civili Brescia - Recruiting Brescia (BS), Italy Fondazione Del Piemonte Per L'Oncologia Ircc Di Candiolo - Recruiting Candiolo (TO), Italy Irst - Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori - Recruiting Meldola (fc), Italy Irccs Istituto Europeo Di Oncologia (Ieo) - Recruiting Milano (MI), Italy Irccs Istituto Nazionale Dei Tumori (Int) Recruiting Milano (MI), Italy Irccs Istituto Nazionale Tumori Fondazione Pascale - Not yet recruiting Napoli (NA), Italy Irccs Istituto Oncologico Veneto (Iov) Recruiting Padova, Italy Irccs Istituto Regina Elena (Ifo) Recruiting Roma (rm), Italy Irccs Istituto Clinico Humanitas - Recruiting Rozzano (mi), Italy Presidio Sanitario Gradenigo Di Torino Not yet recruiting Torino (TO), Italy Spain Hospital Vall D'Hebron Recruiting Barcelona, Spain Hospital Clínico de Malaga Recruiting Malaga, Spain Hospital Son Espases Recruiting Palma de Mallorca, Spain Less <<
NCT01650077 - Unknown December 2014 France ... More >> Bergonie Institute Bordeaux, France, 33 076 Oscar Lambret Center Lille, France, 59020 Cancer Institute of the West Nantes - Saint Therblain, France, 44 805 Antoine Lacassagne Center Nice, France, 06 189 Curie Institute Paris, France, 75 005 Henri Becquerel Center Rouen, France, 76 038 Less <<
NCT03284320 - Active, not recruiting June 2019 Germany ... More >> University Medicine Greifswald, Department of Internal Medicine C Greifswald, Germany, 17475 Less <<
NCT01299506 - Completed - Netherlands ... More >> NKI Amsterdam Amsterdam, Netherlands, 1066 CX UMC Groningen Groningen, Netherlands, 9700 RB Leiden University Leiden, Netherlands, 2300 RC Nijmegen UMCN Nijmegen, Netherlands, 6500 HB Erasmus MC Rotterdam Rotterdam, Netherlands, 3015E Less <<
NCT00060944 Liposarcoma L... More >>eiomyosarcoma Less << Phase 2 Completed - -
NCT02618122 - Active, not recruiting June 2019 Greece ... More >> Thessaloniki Thessaloniki, Greece Less <<
NCT01869400 - Completed - Germany ... More >> Praxis und Tagesklinik für gynäkologische Onkologie Ebersberg, Bayern, Germany, 85567 Diakoniekrankenhaus, Gynäkologie und Geburtshilfe Rotenburg, Lower Saxony, Germany, 27356 Less <<
NCT00060944 - Completed - -
NCT03470805 Ovarian Cancer Phase 2 Recruiting June 2021 Spain ... More >> ICO Badalona Not yet recruiting Badalona, Spain Contact: Margarita Romeo, MD          Principal Investigator: Margarita Romeo, MD          H Reina Sofía Cordoba Not yet recruiting Cordoba, Spain, 14004 Contact: Maria Jesus Rubio, MD          Principal Investigator: Maria Jesus Rubio, MD          Hospital de Guadalajara Not yet recruiting Guadalajara, Spain Contact: Javier Cassinello, MD          Principal Investigator: Javier Cassinello, MD          Complejo Hospitalario de Jaen Not yet recruiting Jaén, Spain Contact: Fernando Gálvez, MD          Principal Investigator: Fernando Gálvez, MD          Hospital de Jerez de la Frontera Not yet recruiting Jerez De La Frontera, Spain Contact: Maria del Mar Gordon, MD          Principal Investigator: Maria del Mar Gordon, MD          Hospital Lucus Augusti Not yet recruiting Lugo, Spain Contact: Lorena Cadavid, MD          Principal Investigator: Lorena Cadavid, MD          Hospital Universitario La Paz Recruiting Madrid, Spain, 28046 Contact: Andrés Redondo, MD          Principal Investigator: Andrés Redondo          Fundación Jimenez Diaz Not yet recruiting Madrid, Spain Contact: Victoria Casado, MD          Principal Investigator: Victoria Casado, MD          Hospital Ramon y Cajal Recruiting Madrid, Spain Contact: Eva Guerra, MD          Principal Investigator: Eva Guerra, MD          Hospital Universitario 12 de Octubre Not yet recruiting Madrid, Spain Contact: Luis Manso Sánchez, M.D.          Principal Investigator: Luis Manso Sánchez, M.D.          Hospital Universitario Puerta de Hierro Not yet recruiting Madrid, Spain Contact: Constanza Maximiano, MD          Principal Investigator: Constanza Maximiano, MD          Hospital Clinico Universitario Virgen Arrixaca Recruiting Murcia, Spain Contact: Jerónimo Martínez, MD          Principal Investigator: Jerónimo Martínez, MD          Hospital Universitario de Valdecilla Recruiting Santander, Spain, 39008 Contact: Ana de Juan, MD          Principal Investigator: Ana de Juan, MD          Hospital Universitario Virgen del Rocío Recruiting Sevilla, Spain Contact: Puri Estévez García, M.D.          Principal Investigator: Puri Estévez García, M.D.          Hospital Virgen Macarena Not yet recruiting Sevilla, Spain Contact: Ana Grueso López, MD          Principal Investigator: Ana Grueso López, MD          Instituto Valenciano de Oncología Not yet recruiting Valencia, Spain, 46009 Contact: Ignacio Romero, MD          Principal Investigator: Ignacio Romero Less <<
NCT01453283 Solid Tumors Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00017030 Sarcoma Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00027508 Malignant Mesothelioma Phase 2 Terminated(Enrolment halted pr... More >>ematurely and not resumed. 2 patients enrolled. No data was obtained.) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00569673 Fallopian Tube Cancer ... More >> Ovarian Cancer Primary Peritoneal Cavity Cancer Less << Phase 2 Completed - -
NCT00003939 Brain and Central Nervous Syst... More >>em Tumors Endometrial Cancer Gastrointestinal Stromal Tumor Ovarian Cancer Sarcoma Small Intestine Cancer Less << Phase 2 Completed - -
NCT00569673 - Completed - -
NCT00002904 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Completed - -
NCT00005625 Sarcoma Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01379989 Ovarian Cancer Phase 3 Active, not recruiting July 2020 -
NCT00006463 Unspecified Childhood Solid Tu... More >>mor, Protocol Specific Less << Phase 1 Completed - -
NCT01189253 Sarcoma Phase 2 Phase 3 Terminated(Results of step1 no... More >>ne of the experimental arms fulfills expectations and the study will not continue as a phase III.) Less << June 2015 -
NCT02204111 - Completed - Germany ... More >> University Hospital Carl Gustav Carus, MK I Dresden, Saxony, Germany, 01307 Charité Berlin, Germany, 13353 Hannover Medical School Hannover, Germany, 30625 University Hospital Koeln Koeln, Germany, 50937 University Medical Centre Mannheim Mannheim, Germany, 68167 University Hospital Muenster Muenster, Germany, 48149 University Hospital Tuebingen Tuebingen, Germany, 72076 Less <<
NCT03022448 - Recruiting January 2021 Austria ... More >> Klinikum Klagenfurt am Wörthersee Recruiting Klagenfurt, Austria Contact: Wolfgang Eisterer, Prof. Dr.          Medizinische Universität Wien Recruiting Wien, Austria Contact: Thomas Brodowicz, Prof. Dr.          Germany HELIOS Klinikum Bad Saarow Recruiting Bad Saarow, Germany Contact: Daniel Pink, Dr.          HELIOS Klinikum Berlin Buch Recruiting Berlin, Germany Contact: Peter Reichardt, PD          Klinikum Spandau Recruiting Berlin, Germany Contact: Annegret Kunitz, Dr.          Universitätsklinikum Carl Gustav Carus der TU Dresden Recruiting Dresden, Germany Contact: Stephan Richter, Dr.          Universitätsklinikum Heidelberg Recruiting Heidelberg, Germany Contact: Gerlinde Egerer, Prof. Dr.          University of Heidelberg Mannheim University Medical Center Interdisciplinary Tumor Center, Sarcoma Unit Recruiting Mannheim, Germany Contact: Bernd Kasper, Prof.    +49 621 383 2580    bernd.kasper@umm.de    Klinikum Nürnberg Nord Recruiting Nürnberg, Germany Contact: Marinela Augustin, Dr.          Universitätsklinikum Ulm Recruiting Ulm, Germany Contact: Verena Gaidzik, Dr.          Switzerland Universitätsspital Bern Recruiting Bern, Switzerland Contact: Attila Kollar, Dr. med.          Kantonsspital St. Gallen Recruiting Saint Gallen, Switzerland Contact: Christian Rothermundt, Dr. Less <<
NCT03690739 Recurrent Ovarian Carcinoma Phase 3 Not yet recruiting December 31, 2023 Germany ... More >> Hochtaunus-Kliniken Bad Homburg, Germany Mammazentrum am Krankenhaus Jerusalem Not yet recruiting Hamburg, Germany Contact: Felix Hilpert Less <<
NCT01846611 Ovarian Neoplasms ... More >> Peritoneal Neoplasms Fallopian Tube Neoplasms Less << Phase 3 Active, not recruiting December 31, 2018 -
NCT03164980 - Recruiting February 2022 Germany ... More >> Gyn-onkologische Schwerpunktpraxis Recruiting Berlin, Germany, 10317 Contact: Severin Pergel       severin.pergel@gyn-onko-lichtenberg.de    Principal Investigator: Jörg Schilling, Dr.          Sub-Investigator: Angelika Till, Dr.          Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum Recruiting Berlin, Germany, 13353 Contact: Isil Yalcinkaya    +(49)30450564404    isil.yalcin@charite.de    Principal Investigator: Jalid Sehouli, Prof. Dr.          Sub-Investigator: Radoslav Chekerov, Dr.          Sub-Investigator: Elena-Ioana Braicu, PD Dr.          Praxis Krebsheilkunde für Frauen Recruiting Berlin, Germany, 13597 Contact: Sabine Seher       studien@medionko.de    Principal Investigator: Gülten Oskay-Özcelik, PD Dr.          Sub-Investigator: Steffen Gläser, Dr.          Medizinisches Zentrum Bonn Friedensplatz Recruiting Bonn, Germany, 53111 Contact: Susanne Herz       s.herz@medizinisches-zentrum-bonn.de    Principal Investigator: Christian Kurbacher, PD Dr.          Sub-Investigator: Jutta Kurbacher          Studien GbR Braunschweig Recruiting Braunschweig, Germany, 38100 Contact: Bibiana Kalensee       kalensee@orenz-hecker-wesche.de    Principal Investigator: Ralf Lorenz, Dr.          Sub-Investigator: Janine Kreiss-Sender, Dr.          Onkologisches Zentrum Donauwörth Recruiting Donauwörth, Germany, 86609 Contact: Katrin Haftmann       onkostudiendon@gmail.com    Principal Investigator: Dirk Hempel, Prof. Dr.          Sub-Investigator: Volker Gressler, Dr.          Frauenklinik Carl Gustav Carus Recruiting Dresden, Germany, 01307 Contact: Christine Griebsch    +(49)3514584202    Christine.griebsch@uniklinikum-dresden.de    Principal Investigator: Pauline Wimberger, Prof. Dr.          Sub-Investigator: Theresa Link, Dr.          Universitätsklinikum Essen Recruiting Essen, Germany, 45147 Contact: Katharina Denzel       Katharina.denzel@uk-essen.de    Principal Investigator: Paul Buderath, Dr.          Sub-Investigator: Pawel March, Dr.          Universitätsklinikum Freiburg Recruiting Freiburg, Germany, 79106 Contact: Caroline Cieslik       caroline.cieslik@uniklinik-freiburg.de    Principal Investigator: Michaela Bossart, PD Dr.          Sub-Investigator: Beate Rautenberg, Dr.          Gemeinschaftspraxis Recruiting Fürth, Germany, 90766 Contact: Traudl Walter       tgd-studies@hotmail.de    Principal Investigator: Harald Wagner, Dr.          Sub-Investigator: Jochen Wilke, Dr.          St. Vincentius-Diakonissen-Kliniken g AG Recruiting Karlsruhe, Germany, 76135 Contact: Lilli Funk       lillli.funk@vincentius-ka.de    Principal Investigator: Oliver Tome, Dr.          Sub-Investigator: Christof Lindner          ZAGO am Helios Klinikum Krefeld Recruiting Krefeld, Germany, 47805 Contact: Songül Uysal       studienabteilung.zago@gmail.com    Principal Investigator: Gunther Rogmans, Dr.          Sub-Investigator: Annette Steffen, Dr.          Universitätsfrauenklinik Leipzig Recruiting Leipzig, Germany, 04103 Contact: Iris Eberhardt       iris.eberhardt@edizin.uni-leipzig.de    Principal Investigator: Bahriye Aktas, Prof. Dr.          Sub-Investigator: Maren Knödler, Dr.          Sub-Investigator: Jens Einenkel, Dr.          Klinik der Otto-von-Guericke-Universität Magdeburg Recruiting Magdeburg, Germany, 39108 Contact: Sabrina Rudolph       sabrina.rudolph@med.ovgu.de    Principal Investigator: Atanas Ignatov, Prof. Dr.          Sub-Investigator: Holm Eggemann, PD Dr.          Universitätsklinik der Johannes Gutenberg-Universität Mainz Recruiting Mainz, Germany, 55131 Contact: Martina Seehase       martina.seehase@unimedizin-mainz.de    Principal Investigator: Marco Battista, Dr.          Sub-Investigator: Annette Hasenburg, Prof. Dr.          Universitätsmedizin Mannheim Recruiting Mannheim, Germany, 68167 Contact: Jessica Merkel       jessica.merkel@umm.de    Principal Investigator: Michael Bohlmann, Prof. Dr.          Sub-Investigator: Sebastian Berlin, PD Dr.          Ruppiner Kliniken GmbH Recruiting Neuruppin, Germany, 16816 Contact: Angelika Krajewsi       a.krajewski@ruppiner-kliniken.de    Principal Investigator: Bernd Christensen, Dr.          Sub-Investigator: Yvonne Schwarz          Caritas Klinikum St. Theresia Recruiting Saarbrücken, Germany, 66113 Contact: Ulrike Schilling       u.schilling@caritasklinikum.de    Principal Investigator: Mustafa Deryal, Dr. med.          Sub-Investigator: Mira Ebner, Dr.          amO Wolfsburg Recruiting Wolfsburg, Germany, 38440 Contact: Clemens Liebrich, Dr.       clemens.liebrich@klinikum.wolfsburg.de    Principal Investigator: Clemens Liebrich, Dr.          Sub-Investigator: Andreas Reichl Less <<
NCT00050440 Endometrial Neoplasms ... More >> Uterine Neoplasms Genital Neoplasms, Female Urogenital Neoplasms Less << Phase 2 Completed - United States, California ... More >> Los Angeles, California, United States United States, Florida Miami, Florida, United States United States, Kentucky Lexington, Kentucky, United States United States, Maryland Baltimore, Maryland, United States United States, New York New York, New York, United States United States, Oklahoma Oklahoma City, Oklahoma, United States United States, Tennessee Nashville, Tennessee, United States United States, Texas Dallas, Texas, United States Canada, Ontario Toronto, Ontario, Canada Netherlands Maastricht, Netherlands Russian Federation Moscow N/A, Russian Federation Moscow, Russian Federation Obninsk N/A, Russian Federation St Petersburg N/A, Russian Federation St Petersburg, Russian Federation St, Russian Federation Less <<
NCT00102609 Soft Tissue Sarcoma ... More >> Sarcoma Neoplasms, Connective and Soft Tissue Neoplasms by Histologic Type Neoplasms Less << Phase 1 Completed - -
NCT00050414 Ovarian Neoplasms ... More >> Endocrine Gland Neoplasms Neoplasms by Site Neoplasms Ovarian Diseases Adnexal Diseases Genital Diseases, Female Less << Phase 2 Completed - -
NCT00050427 Breast Neoplasms ... More >> Neoplasms Neoplasms by Site Breast Diseases Skin Diseases Less << Phase 2 Completed - -
NCT01273480 Neoplasm Metastases Phase 1 Completed - United States, Pennsylvania ... More >> Philadelphia, Pennsylvania, United States United States, Utah Salt Lake City, Utah, United States Less <<
NCT00210665 Sarcoma NO_LONGER_AVAILABLE - Anchorage, Alaska, United Stat... More >>es|San Diego, California, United States|Santa Monica, California, United States|Aurora, Colorado, United States|Daytona Beach, Florida, United States|Hollywood, Florida, United States|Atlanta, Georgia, United States|Coeur d'Alene, Idaho, United States|Park Ridge, Illinois, United States|Iowa City, Iowa, United States|Overland Park, Kansas, United States|Louisville, Kentucky, United States|Metairie, Louisiana, United States|Baltimore, Maryland, United States|Boston, Massachusetts, United States|Ann Arbor, Michigan, United States|Detroit, Michigan, United States|Rochester, Minnesota, United States|Saint Joseph, Missouri, United States|Omaha, Nebraska, United States|Newark, New Jersey, United States|New York, New York, United States|Cleveland, Ohio, United States|Tulsa, Oklahoma, United States|Portland, Oregon, United States|Philadelphia, Pennsylvania, United States|Charleston, South Carolina, United States|Houston, Texas, United States|San Antonio, Texas, United States|Seattle, Washington, United States|Milwaukee, Wisconsin, United States|Calgary, Alberta, Canada|Edmonton, Alberta, Canada|Toronto, Ontario, Canada|Edmonton N/A, Canada|Tel Aviv, Israel Less <<
NCT00796120 Sarcoma Phase 3 Completed - United States, California ... More >> Santa Monica, California, United States United States, Massachusetts Boston, Massachusetts, United States United States, New Mexico Albuquerque, New Mexico, United States United States, Pennsylvania Philadelphia, Pennsylvania, United States United States, Texas Houston, Texas, United States United States, Utah Salt Lake City, Utah, United States France Boreaux, France Lille, France Lyon, France Paris, France Villejuif, France Germany Bad Saarow, Germany Köln, Germany Mannheim, Germany Spain Barcelona, Spain Palma De Mallorca N/A, Spain Valencia N/A, Spain United Kingdom Edinburgh, United Kingdom Glasgow, United Kingdom London, United Kingdom Manchester, United Kingdom Less <<
NCT00796120 - Completed - -
NCT02131480 Uterus Leiomyosarcoma ... More >> Soft Tissue Leiomyosarcoma Less << Phase 2 Completed - France ... More >> Gustave Roussy Cancer Campus Grand Paris Villejuif, Val de Marne, France, 94805 Less <<
NCT02509234 - Unknown July 2017 -
NCT00070109 Previously Treated Childhood R... More >>habdomyosarcoma Recurrent Childhood Rhabdomyosarcoma Recurrent Childhood Soft Tissue Sarcoma Recurrent Ewing Sarcoma Peripheral Primitive Neuroectodermal Tumor Less << Phase 2 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 United States, California Children's Hospital Central California Madera, California, United States, 93636-8762 United States, Illinois Childrens Memorial Hospital Chicago, Illinois, United States, 60614 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 New York University Langone Medical Center New York, New York, United States, 10016 Columbia University Medical Center New York, New York, United States, 10032 United States, North Carolina Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Vermont University of Vermont Burlington, Vermont, United States, 05401 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Canada, Ontario Chedoke-McMaster Hospitals Hamilton, Ontario, Canada, L8S 4L8 Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Canada, Quebec Hospital Sainte-Justine Montreal, Quebec, Canada, H3T 1C5 Less <<
NCT02997358 Uterine or Soft Tissue Leiomyo... More >>sarcoma Less << Phase 3 Not yet recruiting December 2020 France ... More >> Gustave Roussy Active, not recruiting Villejuif, Val de Marne, France, 94805 Less <<
NCT00113607 Ovarian Cancer Phase 3 Completed - -
NCT00113607 - Completed - -
NCT01343277 Advanced Liposarcoma or Leiomy... More >>osarcoma Less << Phase 3 Completed - -
NCT00379145 Sarcoma Phase 2 Completed - -
NCT03138161 Advanced Soft Tissue Sarcoma ... More >> Metastatic Soft Tissue Sarcoma Less << Phase 1 Phase 2 Recruiting August 31, 2020 United States, California ... More >> Sarcoma Oncology Research Center Recruiting Santa Monica, California, United States, 90403 Contact: Erlinda M Gordon, MD    310-552-9999    egordon@sarcomaoncology.com    Contact: Victoria Chua-Alcala    310-552-9999    vchua@sarcomaoncology.com    Principal Investigator: Erlinda M Gordon, MD          Sub-Investigator: Sant P Chawla, MD          Sub-Investigator: Kamalesh K Sankhala, MD          Sub-Investigator: Doris V Quon, MD          Sub-Investigator: William W Tseng, MD Less <<
NCT00070109 - Completed - -
NCT01267084 Neoplasm Metastases Phase 1 Phase 2 Completed - Belgium ... More >> Brussel, Belgium Wilrijk, Belgium Less <<
NCT00580112 Breast Neoplasms Phase 2 Completed - -
NCT00379145 - Completed - -
NCT00579501 Liposarcoma,Myxoid Phase 2 Completed - United States, Idaho ... More >> Coeur D Alene, Idaho, United States United States, Illinois Park Ridge, Illinois, United States United States, Iowa Iowa City, Iowa, United States United States, Massachusetts Boston, Massachusetts, United States France Bourdeaux, France Lyon, France Villejuif, France Germany Mannheim, Germany Less <<
NCT00579501 - Completed - -
NCT01343277 - Completed - -
NCT02163720 - Completed - France ... More >> Centre de Radiothérapie et d'Oncologie Agen, France Clinique de l'Europe Amiens, France ICO Paul Papin Angers, France, 49100 Hôpital de la Côte Basque Bayonne, France, 64100 Hôpital jean Minjoz Besancon, France Clinique Tivoli Bordeaux, France Hôpital Fleyriat Bourg-En-Bresse, France Hôpital Morvan - Centre Hospitalier Universitaire Brest, France, 29200 Cabinet d'Oncologie - Hôpital Privé Sainte Marie Chalon Sur Saone, France, 71100 Centre Hospitalier de Cholet Cholet, France Hôpital Privé Drôme Ardèche - Clinique Pasteur Guilherand-granges, France, 07500 Hôpital Louis Pasteur Le Coudray, France, 28630 Centre Oscar Lambret Lille, France Centre Hospitalier Universitaire Dupuytren Limoges, France, 87042 CHU Dupuytren Limoges, France Centre Léon Bérard Lyon, France, 69373 institut Paoli Calmette Marseille, France Centre Azuréen de Cancérologie Mougins, France Centre d'oncologie de Gentilly Nancy, France Centre Hospitalier Régional Orléans, France Hôpital Tenon Paris, France, 75020 Hôpital de la Milétrie - Centre Hospitalier Universitaire de Poitiers - Pôle Régional de Cancérologie Poitiers, France, 86021 Clinique Courlancy Reims, France, 51100 Institut Jean Godinot Reims, France Clinique Armoricaine de Radiologie Saint Brieuc, France ICO Centre René Gauducheau Saint Herblain, France, 44805 Clinique de l'Union Saint Jean, France, 31240 Clinique de l'Alliance Saint-cyr-sur-loire, France GHPSO - Site Senlis Senlis, France, 60309 Centre de Radiothérapie - Clinique Sainte-Anne Strasbourg, France, 67000 Clinique Saint Jean Toulon, France Institut Claudius Regaud Toulouse, France, 31059 Institut de Cancérologie Gustave Roussy Villejuif, France, 94805 Less <<
NCT00147212 Prostate Cancer Phase 2 Completed - United States, Massachusetts ... More >> Masachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00072670 Prostate Cancer PHASE2 COMPLETED 2025-11-08 Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114-2617, United States Less <<
NCT00147212 - Completed - -
NCT02903004 Ovarian Neoplasms Phase 3 Recruiting April 2020 Italy ... More >> Domenica Lorusso Recruiting Milan, Italy, 20133 Contact: Domenica Lorusso, MD    +390223903697    domenica.lorusso@istitutotumori.mi.it    Contact: Elisa Grassi    +390223903818    elisa.grassi@istitutotumori.mi.it Less <<
NCT03127215 Cancers With DNA Repair-Defici... More >>ency Less << Phase 2 Recruiting March 31, 2021 Germany ... More >> National Center for Tumordiseases (NCT) Recruiting Heidelberg, Germany, 69120 Contact: R. Schlenk, MD    +49622156 ext 6228    studienzentrale@nct-heidelberg.de Less <<
NCT01427582 Soft Tissue Sarcoma NO_LONGER_AVAILABLE - University of Texas Southweste... More >>rn, Dallas, Texas, 75390, United States Less <<
NCT03074318 Metastatic Leiomyosarcoma ... More >> Metastatic Liposarcoma Unresectable Leiomyosarcoma Unresectable Liposarcoma Less << Phase 1 Phase 2 Recruiting September 15, 2020 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Seth M. Pollack    206-667-6629    spollack@fredhutch.org    Principal Investigator: Seth M. Pollack Less <<
NCT02672527 Soft Tissue Sarcoma Phase 3 Completed - France ... More >> Gustave Roussy Cancer Campus Grand Paris Villejuif, Val De Marne, France, 94805 Less <<
NCT03023124 Solitary Fibrous Tumors Phase 2 Recruiting March 2024 Italy ... More >> Fondazione IRCCS Istituto Nazionale dei Tumori Not yet recruiting Milano, MI, Italy, 20133 Contact: Silvia Stacchiotti, MD       silvia.stacchiotti@istitutotumori.mi.it    Principal Investigator: Silvia Stacchiotti, MD          Policlinico Universitario Campus Biomedico Not yet recruiting Roma, RM, Italy, 00128 Contact: Bruno Vincenzi, MD    +3902225411123    b.vincenzi@unicampus.it    Principal Investigator: Bruno Vincenzi, MD          Fondazione Del Piemonte Per L'Oncologia Ircc Di Candiolo - Recruiting Candiolo, Italy, 10060 Ospedale Giaccone Not yet recruiting Palermo, Italy Contact: Giuseppe Badalamenti, MD Less <<
NCT01339754 Pancreatic Cancer Phase 2 Completed - Italy ... More >> Istituto Scientifico H. San Raffaele Milan, Italy, 20132 Less <<
NCT03397186 Myxoid Liposarcoma ... More >> Round Cell Liposarcoma Stage III Soft Tissue Sarcoma AJCC v7 Stage IV Soft Tissue Sarcoma AJCC v7 Less << Phase 2 Recruiting May 1, 2019 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Seth M. Pollack    206-667-6629       Principal Investigator: Seth M. Pollack Less <<
NCT02805725 Soft-tissue Sarcomas Phase 1 Phase 2 Recruiting December 2019 France ... More >> Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Antoine ITALIANO, MD,PhD          Principal Investigator: Antoine ITALIANO, MD,PhD          Centre Léon Bérard Not yet recruiting Lyon Cedex 08, France, 69373 Contact: Jean-Yves BLAY          Principal Investigator: Jean-Yves BLAY, MD,PhD          Institut Gustave Roussy Not yet recruiting Villejuif Cedex, France, 94805 Contact: Sarah DUMONT, MD          Principal Investigator: Sarah DUMONT, MD Less <<
NCT01273493 Neoplasm Metastases ... More >> Hepatic Insufficiency Less << Phase 1 Completed - United States, Arizona ... More >> Scottsdale, Arizona, United States United States, Michigan Detroit, Michigan, United States United States, New York New York, New York, United States United States, Pennsylvania Philadelphia, Pennsylvania, United States United States, Utah Salt Lake City, Utah, United States United States, Washington Tacoma, Washington, United States Belgium Edegem, Belgium Wilrijk, Belgium Canada, Alberta Edmonton, Alberta, Canada Spain Barcelona, Spain Madrid, Spain Less <<
NCT02825420 - Recruiting December 2019 -
NCT03590210 Metastatic Adult Soft Tissue S... More >>arcoma Less << Phase 2 Recruiting July 2021 Germany ... More >> Helios Klinikum Bad Saarow, Klinik für Hämatologie, Onkologie und Palliativmedizin, Sarkomzentrum Berlin-Brandenburg Recruiting Bad Saarow, Germany, 15526 Contact: Carola Schuppan          Principal Investigator: Daniel Pink, MD          Helios Klinikum Berlin Buch, Klinik für interdisziplinäre Onkologie, Sarkomzentrum Berlin-Brandenburg Recruiting Berlin, Germany, 13125 Contact: Marie Ritter          Principal Investigator: Peter Reichardt, MD          Universitätsmedizin Greifswald, Klinik und Poliklinik für Innere Medizin C, Hämatologie und Onkologie Active, not recruiting Greifswald, Germany, 17475 Less <<
NCT01426633 Leiomyosarcoma ... More >> Liposarcoma Less << Phase 1 Completed - Germany ... More >> Mannheim University Medical Center Mannheim, Germany, 68167 Less <<
NCT02275286 Liposarcoma, Myxoid ... More >> Sarcoma, Soft Tissue Less << Phase 1 Phase 2 Recruiting June 2018 France ... More >> Institut Bergonié Recruiting Bordeaux, France, 33000 Contact: Antoine Italiano, MD          Centre Oscar Lambret Not yet recruiting Lille, France, 59000 Contact: Nicolas Penel, MD          Centre Léon Berard Recruiting Lyon, France Principal Investigator: Jean Yves Blay, MD          Italy Istituto Clinico Humanitas Not yet recruiting Rozzano, Milan, Italy, 20089 Contact: Armando Santoro, MD          Centro di Referimento Ocologico Not yet recruiting Aviano, Italy, 33081 Contact: Angela Buonadonna, MD          Istituto Ortopedico Rizzoli Not yet recruiting Bologna, Italy, 40136 Contact: Stefano Ferrari , MD          Istituto Oncologico Recruiting Candiolo, Italy, 10060 Contact: Giovanni Grignani, MD          Istituto Nazionale dei Tumori Recruiting Milan, Italy, 20133 Contact: Alessandro Gronchi, MD       alessandro.gronchi@istitutotumori.mi.it    Spain Hospital Miguel Servet Recruiting Zaragoza, Aragón, Spain, 50009 Contact: Javier Martínez-Trufero, MD          Hospital Sant Pau Recruiting Barcelona, Cataluña, Spain, 08041 Contact: Antonio Lopez-Posa, MD          Hospital Son Espases Recruiting Palma de Mallorca, Mallorca, Spain, 07010 Contact: Pablo Luna, MD          Hospital Universitario Canarias Recruiting San Cristobal de la Laguna, Tenerife, Spain, 38320 Contact: Josefina Cruz, MD          Hospital Vall d'Hebrón Recruiting Barcelona, Spain, 08035 Contact: Claudia Valverde, MD          Hospital Puerta de Hierro Recruiting Madrid, Spain, 28006 Contact: Ricardo Cubedo, MD          Hospital Universitario Gregorio Marañón Recruiting Madrid, Spain, 28007 Contact: Rosa Álvarez, MD          Hospital Uniersitario La Paz Recruiting Madrid, Spain, 28046 Contact: Andres Redondo, MD          Hospital Virgen del Rocío Recruiting Sevilla, Spain, 41013 Contact: Javier Martín-Broto, MD       javier.martin@ssib.es Less <<
NCT00786838 - Completed - -
NCT01303094 Soft Tissue Sarcoma ... More >> Uterine Sarcoma Less << Phase 2 Unknown February 2017 France ... More >> Saint-Jacques Hospital Besancon, France, 25 000 Institut Bergonié Bordeaux, France, 33076 Centre François Baclesse Caen, France, 14076 Centre Jean Perrin Clermont Ferrand, France, 63011 Centre Georges François Leclerc Dijon, France, 21079 Centre Oscar Lambret Lille, France, 59020 Léon Bérard Center Lyon, France, 69 008 Centre Léon Bérard Lyon, France, 69008 Paoli Calmette Institute Marseille, France, 13 273 CHU Timone Adultes Marseille, France, 13385 Centre Antoine Lacassagne Nice, France, 06189 Institut Curie Paris, France, 75005 Centre Henri Becquerel Rouen, France, 76038 Centre René Huguenin St Cloud, France, 92210 Institut Claudius Regaud Toulouse, France, 31052 Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT03437070 Leiomyosarcoma Phase 1 Recruiting October 2022 United States, Florida ... More >> University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Marilyn Huang, MD, MS    305-243-2233    m.huang@med.miami.edu Less <<
NCT01735071 Ovarian Epithelial Cancer Recu... More >>rrent Less << Phase 2 Active, not recruiting December 2018 Italy ... More >> Azienda Ospedaliera Spedali Civili di Brescia Brescia, Italy AO Fatebenefratelli e Oftalmico Milano, Italy Istituto Europeo di Oncologia Milan, Italy Azienda Ospedaliera S. Gerardo Monza, Italy Istituto Oncologico Veneto Padova, Italy Policlinico Universitario Agostino Gemelli di Roma Roma, Italy Mauriziano Hospital Torino, Italy Less <<
NCT02066675 Metastatic and Locally Advance... More >>d Soft Tissue Tumor Patients Unfit to Receive|Standard Chemotherapy Less << PHASE2 COMPLETED 2016-12-31 Ospedali Riuniti di Bergamo, B... More >>ergamo, BG, Italy|Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST, Meldola, FC, Italy|Ospedale Galliera, Genova, Genovs, Italy|IRCCS Azienda Ospedaliera Universitaria San Martino IST, Genova, GE, Italy|Ospedale Villa Scassi, Genova, GE, Italy|Ospedale Misericordia e Dolce" Istituto Toscano Tumori, Azienda USL4, Prato, PO, Italy|I.R.C.C. - Unit of Medical Oncology, Candiolo, Torino, 10060, Italy|Presidio Sanitario Gradenigo, Torino, TO, 10153, Italy|A.S.O. "SS Antonio e Biagio e Cesare Arrigo", Alessandria, Italy|Istituti Ortopedici Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors, Bologna, 40136, Italy|Ospedale SS. Trinità di Sora, Frosinone, Italy|IST, Genova, Italy|Policlinico Federico II Napoli, Napoli, Italy|Istituto Oncologico Veneto, Padova, Italy|Ospedale Giaccone, Palermo, Italy|Campus Biomedico, Roma, Italy Less <<
NCT01692678 Advanced or Metastatic Liposar... More >>coma or Leiomyosarcoma Less << Phase 3 Completed - China ... More >> Beijing, China Shanghai, China Less <<
NCT00786838 Solid Tumor Phase 2 Completed - United States, Florida ... More >> Miami, Florida, United States United States, North Carolina Charlotte, North Carolina, United States United States, Pennsylvania Philadelphia, Pennsylvania, United States United States, Washington Tacoma, Washington, United States Belgium Brussels, Belgium Edegem, Belgium Wilrijk, Belgium France Lyon, France Marseille, France Montpellier, France Villejuif, France India Bangalore N/A, India Pune, India Korea, Republic of Seoul, Korea, Republic of Russian Federation Moscow N/A, Russian Federation Moscow, Russian Federation St Petersburg N/A, Russian Federation St-Petersburg, Russian Federation Spain Sanchinarro, Spain Less <<
NCT02234050 Recurrent High Grade Meningiom... More >>a Less << Phase 2 Active, not recruiting - -
NCT02249702 Leiomyosarcoma Phase 2 Completed - Italy ... More >> Centro di Riferimento Oncologico Aviano, Pordenone, Italy Policlinico Umberto I Roma, RM, Italy, 00186 Fondazione del Piemonte per l'Oncologia Candiolo, Turin, Italy Azienda ULSS 13 Regione Veneto, Ospedale di Mirano Mirano, Venice, Italy Ospedale Sacro Cuore Don Calabria Negrar, Verona, Italy Azienda Ospedaliera Nazionale SS. Antonio e Biagio e C. Arrigo Alessandria, Italy Azienda Ospedaliera Spedali Civili di Brescia Brescia, Italy Presidio Ospedaliero Senatore Antonio Perrino Brindisi, Italy Azienda Ospedaliera per l'Emergenza Cannizzaro Catania, Italy Ospedale Sant'Anna Como, Italy Azienda Ospedaliera S. Croce e Carle Cuneo, Italy Azienda Ospedaliera Universitaria San Martino - IST Genoa, Italy Ente Ospedaliero Ospedali Galliera Genova, Italy Azienda USL 2 Toscana - Nuovo Ospedale San Luca Lucca, Italy Istituto Nazionale dei Tumori di Milano Milano, Italy Istituto Clinico Humanitas Milan, Italy Istituto Europeo di Oncologia Milan, Italy Istituto Nazionale dei Tumori di Milano Milan, Italy Azienda Ospedaliera San Gerardo Monza, Italy Istituto Nazionale Tumori - Fondazione Pascale Napoli, Italy Azienda Ospedaliero Universitaria Maggiore della Carità Novara, Italy Istituto Oncologico Veneto Padova, Italy Azienda Ospedaliera Ospedali Riuniti Villa Sofia - Cervello Palermo, Italy Azienda Ospedaliero-Universitaria di Parma Parma, Italy Policlinico San Matteo Pavia, Italy Azienda Ospadaliero-Universitaria Pisana Pisa, Italy Azienda Ospedaliera Regionale San Carlo Potenza, Italy Azienda Ospedaliera Arcispedale S. Maria Nuova Reggio Emilia, Italy Ospedale San Giovanni Calibita Fatebenefratelli Roma, Italy Policlinico Umberto I - Università Sapienza Roma, Italy Policlinco Universitario Agostino Gemelli Rome, Italy Azienda Ospedaliera Ordine Mauriziano Torino, Italy Azienda Ospedaliero-Universitaria di Torino - Presidio Sant'Anna Torino, Italy Presidio Sanitario Gradenigo Torino, Italy Less <<
NCT02398058 Soft Tissue Sarcoma ... More >> Bone Tumor Less << Phase 1 Active, not recruiting January 2019 Italy ... More >> Fondazione del Piemonte per l'Oncologia IRCC Candiolo Candiolo, Torino, Italy, 10060 Istituti Ortopedici Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors Bologna, Italy, 40136 Istituto Nazionale Tumori - Unit of Medical Oncology Milano, Italy, 20133 Less <<
NCT02367924 - Recruiting December 2020 Germany ... More >> Dokusan GmbH und Co. KG; Praxisklinik Herne / Onkologie Recruiting Herne, Nordrhein-Westfalen, Germany, 44623 Contact: Hahn Lars, Dr.    +49-2323 960 5340    l.hahn@dokusan.de    MVZ Marien-Hospital-Wesel GmbH Recruiting Wesel, Nordrhein-Westfalen, Germany, 46483 Contact: Mathias Hoiczyk, Dr.    +49-281-104 ext 1910    mathias.hoiczyk@prohomine.de    Onkologische Gemeinschaftspraxis Dr. med. Mohm & Dr. med. Prange-Krex Recruiting Dresden, Sachsen, Germany, 01307 Contact: Gabriele Prange-Krex, Dr.    +49-351 4416018    mohm@onkopraxis-dresden.de    Praxis Dr. med. Jens Uhlig Recruiting Naunhof, Sachsen, Germany, 04683 Contact: Jens Uhlig, Dr.    +49-34293 4799 76    dr.uhlig@onkologie-muldental.de    Praxis für Innere Medizin, Hämatologie u. Onkologie Recruiting Bremen, Germany, 28209 Contact: Gabriele Doering, Dr.    +49-421 696096 ext 24    dr.doering@nord-com.net Less <<
NCT01104298 Sarcoma Phase 2 Terminated(Interim analysis di... More >>d not show good results for main objective) Less << - Spain ... More >> Ico Hospitalet L'Hospitalet, Barcelona, Spain ICO Badalona Badalona, Spain H. Clinic Barcelona Barcelona, Spain H. Sant Pau Barcelona, Spain H. Provincial Castellón Castellón, Spain ICO Girona Girona, Spain H. Xeral Cies Lugo, Spain Clinica Puerta Hierro Madrid, Spain H. Clínico. San Carlos Madrid, Spain H. U. La Paz Madrid, Spain H.U. Gregorio Marañon Madrid, Spain H.U. Ramon Y Cajal Madrid, Spain H.U. Clinico de Malaga Málaga, Spain H. de Navarra Navarra, Spain H. C. Asturias Oviedo, Spain H. Son Dureta Palma de Mallorca, Spain H. Univ. Canarias Santa Cruz de Tenerife, Spain H.U. Virgen Del Rocio Sevilla, Spain Instituto Valenciano de Oncología Valencia, Spain H. Miguel Servet Zaragoza, Spain Less <<
NCT02929394 Sarcoma, Soft Tissue PHASE3 TERMINATED 2020-06-05 Institut Bergonie, Bordeaux, 3... More >>3076, France|Centre Oscar Lambret, Lille, 59020, France|Centre Leon Berard, Lyon, 69008, France|Assistance Publique - Hopitaux de Marseille - H?pital de La Timone, Marseille, 13385, France|Institut Curie, Paris, 75248, France|Gustave Roussy, Villejuif, 94805, France|Medizinische Hochschule Hannover, Hannover, 30625, Germany|UniversitaetsMedizin Mannheim, Mannheim, 68167, Germany|Leiden University Medical Center, Leiden, Netherlands|Maria Sklodowska-Curie Memorial Cancer Centre, Warsaw, 02 781, Poland|Institut Catala d'Oncologia - ICO L'Hospitalet - Hospital Duran i Reynals, Barcelona, 08907, Spain|Institut Catala d'Oncologia - ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia), Barcelona, 08916, Spain|Hospital Universitario San Carlos, Madrid, 28040, Spain|Royal Marsden Hospital - Chelsea, London, London, SW3 6JJ, United Kingdom Less <<
NCT02359474 Sarcoma Not Applicable Unknown - Germany ... More >> Ludwig-Maximilians University of Munich, Klinikum Großhadern Recruiting Munich, Bavaria, Germany, 81377 Contact: Eric Kampmann, MD    0049894400 ext 74768    sarkum@med.uni-muenchen.de Less <<
NCT01772979 BRCA1 and BRCA2 Mutation Carri... More >>er and BRCAness Phenotype Less << PHASE2 UNKNOWN 2025-06-14 Catholic University of Sacred ... More >>Heart, Rome, 00100, Italy Less <<
NCT02993705 Carcinosarcoma, Ovarian|Carcin... More >>osarcomas Uterine Less << PHASE2 COMPLETED 2019-11-13 Fondazione Policlinico Univers... More >>itario Agostino Gemelli IRCCS, Rome, 00168, Italy Less <<
NCT02394015 - Unknown December 2016 -
NCT03496519 Solid Tumor, Adult Phase 1 Withdrawn(Contract Issues) October 31, 2021 -
NCT03773510 Leiomyosarcoma ... More >> Liposarcoma Synovial Sarcoma Less << Phase 3 Not yet recruiting October 1, 2025 Italy ... More >> A.O. SS Antonio e Biagio e Cesare Arrigo Not yet recruiting Alessandria, AL, Italy, 15100 Contact: Federica Grosso, MD    +390131206155    fgrosso@ospedale.al.it    Principal Investigator: Federica Grosso, ND          Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST Not yet recruiting Meldola, FC, Italy Contact: Toni Ibrahim, MD          Contact       toni.ibrahim@irst.emr.it    Principal Investigator: Toni Ibrahim, MD          Istituto Europeo di Oncologia Not yet recruiting Milano, MI, Italy, 20141 Contact: Tommaso M. De Pas, MD    +390257489482    tommaso.de-pas@ieo.it    Principal Investigator: Tommaso M. De Pas, MD          Istituto Clinico Humanitas Not yet recruiting Rozzano, MI, Italy, 20089 Contact: Alexia Bertuzzi, MD    +390282244540    alexia.bertuzzi@cancercenter.humanitas.it    Principal Investigator: Alexia Bertuzzi, MD          Centro di Riferimento Oncologico di Aviano Not yet recruiting Aviano, PD, Italy, 33081 Contact: Angela Buonadonna, MD    +39 0434 659190    abuonadonna@cro.it    Principal Investigator: Angela Buonadonna, MD          Policlinico Universitario Campus Biomedico Not yet recruiting Roma, RM, Italy, 00128 Contact: Bruno Vincenzi, MD    +3902225411123    b.vincenzi@unicampus.it    Principal Investigator: Bruno Vincenzi, MD          Fondazione del Piemonte per l'Oncologia IRCC Candiolo Not yet recruiting Candiolo, Torino, Italy, 10060 Contact: Giovanni Grignani, MD    0039-011-9933623    giovanni.grignani@ircc.it    Contact: Lorenzo D'Ambrosio, MD    0039-011-9933623    lorenzo.dambrosio@ircc.it    Principal Investigator: Giovanni Grignani, MD          Sub-Investigator: Lorenzo D'Ambrosio, MD          Ospedale Gradenigo Not yet recruiting Torino, TO, Italy, 10153 Contact: Alessandro Comandone, MD    +390118151271    alessandro.comandone@gradenigo.it    Principal Investigator: Alessandro Comandone, MD          Istituto Ortopedico Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors Not yet recruiting Bologna, Italy, 40136 Contact: Emanuela Palmerini, MD    +390516366199 ext 199    emanuela.palmerini@ior.it    Principal Investigator: Emanuela Palmerini, MD          Azienda ospedaliero Universitaria Careggi di Firenze Not yet recruiting Firenze, Italy Contact: Lorenzo Livi, MD          Contact       l.livi@dfc.unifi.it    Principal Investigator: Lorenzo Livi, MD          Fondazione IRCCS INT Milano Not yet recruiting Milano, Italy, 20133 Contact: Roberta Sanfilippo, MD    +390223903 ext 468    roberta.sanfilippo@istitutotumori.mi.it    Principal Investigator: Roberta Sanfilippo, MD          Policlinico Federico II Not yet recruiting Napoli, Italy Contact: Mario Giuliano, Prof          Contact       m.giuliano@unina.it    Principal Investigator: Sabino De Placido, MD          Irccs Istituto Oncologico Veneto (Iov) Not yet recruiting Padova, Italy Contact: Antonella Brunello, MD          Principal Investigator: Antonella Brunello, MD          Ospedale Giaccone Not yet recruiting Palermo, Italy Contact: Giuseppe Giuseppe, MD          Principal Investigator: Giuseppe Giuseppe, MD          Istituti Fisioterapici Ospitalieri di Roma Not yet recruiting Roma, Italy Contact: Virginia Ferraresi, MD          Contact       virginia.ferraresi@ifo.gov.it    Principal Investigator: Virginia Ferraresi, MD Less <<
NCT02194231 Malignant Pleural Mesothelioma PHASE2 COMPLETED 2019-12-12 Azienda ospedaliera ss. Antoni... More >>o e Biagio e Cesare Arrigo, Alessandria, AL, Italy|Cliniche Humanitas Gavazzeni, Bergamo, BG, Italy|Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi, Bologna, Bo, 40138, Italy|P.O. Spedalli Civili, Brescia, BS, 25125, Italy|Azienda Ospedaliera S. Gerardo di Monza, Monza, MB, 20900, Italy|Istituto Clinico Humanitas, Rozzano, MI, 20089, Italy|Istituto Oncologico Veneto - IOV, Padova, PD, 35128, Italy|Azienda Ospedaliro-Universitaria di Parma, Parma, 43126, Italy Less <<
NCT03446495 - Recruiting May 20, 2019 Kazakhstan ... More >> Almaty oncological center Recruiting Almaty, Kazakhstan Contact: Rinat Baituganov, PhD    +7 (727) 382 61 60    almaty.onco@mail.ru    Principal Investigator: Rinat Baituganov, PhD          Almaty regional oncological dispensary Recruiting Almaty, Kazakhstan Contact: Sayakhat Olzhaev, PhD    +77273993881    arod_priem@mail.ru    Principal Investigator: Sayakhat Olzhaev, PhD          Kazakh institute of oncology and radiology Recruiting Almaty, Kazakhstan Contact: Dilara Kaidarova, Academician    + 7 727 292 00 61    admin@ncc.org.kz    Principal Investigator: Dilara Kaidarova, academician          Kazakh institute of oncology and radiology Recruiting Almaty, Kazakhstan Contact: Oxana Shatkovskaya, PhD    +77014147124    1972arty@mail.ru    Principal Investigator: Oxana Shatkovskaya, PhD          Astana Oncology Center Recruiting Astana, Kazakhstan Contact: Mukhtar Tuleutaev, PhD    +77172560073       Principal Investigator: Mukhtar Tuleutaev, PhD          Kyzylorda regional Oncological center Recruiting Kyzylorda, Kazakhstan Contact: Saken Sergaziyev, PhD    +77242235468    onkolog_kzo@mail.ru    Principal Investigator: Saken Sergaziyev, PhD          West Kazakhstan regional oncology dispensary Recruiting Oral, Kazakhstan Contact: Esengeldy Rabaev, PhD          Principal Investigator: Esengeldy Rabaev, PhD          North Kazakhstan Regional Oncology Center Recruiting Petropavlovsk, Kazakhstan Contact: Ermek Abdrimov, PhD    +77152463201    sko.ood@mail.ru    Principal Investigator: Ermek Abdrimov, PhD          South Kazakhstan regional oncologic dispensary Recruiting Shymkent, Kazakhstan Contact: Dauranbek Arybzhanov, PhD    +77252221904    onco-shm@mail.ru    Principal Investigator: Dauranbek Arybzhanov, ЗрВ          East Kazakhstan Regional Oncology Dispensary Recruiting Ust-Kamenogorsk, Kazakhstan Contact: Gulmira Sagidullina, PhD    +77112705976    vkood_poliklinika@mail.ru    Principal Investigator: Gulmira Sagidullina, PhD Less <<
NCT02247544 Liposarcoma|Leiomyosarcoma PHASE2 COMPLETED 2019-03-12 Istituto Tumori Giovanni Paolo... More >> II, Bari, BA, 70124, Italy|Azienda Ospedaliera Giovanni Paolo XXIII, Bergamo, BG, 24127, Italy|Azienda Ospedaliera S. Orsola-Malpighi, Bologna, BO, 40138, Italy|A.O. Spedali Civili, Brescia, BS, 25123, Italy|Ospedale Oncologico A. Businco, Cagliari, CA, 09122, Italy|Azienda Ospedaliera S Croce e Carle, Cuneo, CN, 12100, Italy|Azienda Ospedaliera Sant'Anna, Como, CO, 22020, Italy|IRST IRCCS Meldola, Meldola, FC, 47014, Italy|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, MI, 20133, Italy|Istituto Europeo di Oncologia, Milano, MI, 20141, Italy|Istituto Clinico Humanitas, Rozzano, MI, 20089, Italy|Azienda Ospedaliera Universitaria Paolo Giaccone, Palermo, PA, 90127, Italy|Centro di Riferimento Oncologico di Aviano, Aviano, PD, 33081, Italy|Istituto Oncologico Veneto, Padova, PD, 35128, Italy|Azienda Ospedaliera Universitaria Santa Chiara, Pisa, PI, 56124, Italy|Ospedale Misericordia e Dolce, Prato, PO, 59100, Italy|Policlinico Universitario Campus Biomedico, Roma, RM, 00128, Italy|Istituto per la Ricerca e la Cura del Cancro di Candiolo, Candiolo, TO, 10060, Italy|Ospedale Gradenigo, Torino, TO, 10153, Italy|Azienda Ospedaliera Santa Maria, Terni, TR, 05100, Italy|Istituto Nazionale Tumori - IRCCS - Fondazione Pascale, Napoli, 80131, Italy Less <<
NCT02793050 Sarcoma, Soft Tissue COMPLETED 2018-10-02 A.O. SS Antonio e Biagio e Ces... More >>are Arrigo, Alessandria, AL, 15100, Italy|Istituto Tumori Giovanni Paolo II, Bari, BA, 70124, Italy|Ospedali Riuniti di Bergamo, Bergamo, BG, Italy|Ospedale Oncologico A. Businco, Cagliari, CA, 09122, Italy|Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST, Meldola, FC, Italy|Istituto Europeo di Oncologia, Milano, MI, 20141, Italy|Istituto Clinico Humanitas, Rozzano, MI, 20089, Italy|Azienda Ospedaliera Universitaria Paolo Giaccone, Palermo, PA, 90127, Italy|Centro di Riferimento Oncologico di Aviano, Aviano, PD, 33081, Italy|Istituto Oncologico Veneto, Padova, PD, 35128, Italy|Azienda Ospedaliera Universitaria Santa Chiara, Pisa, PI, 56124, Italy|Policlinico Universitario Campus Biomedico, Roma, RM, 00128, Italy|Fondazione del Piemonte per l'Oncologia IRCC Candiolo, Candiolo, Torino, 10060, Italy|Istituto Ortopedico Rizzoli, Bologna, 40136, Italy|Policlinico S.Orsola Malpighi - Unit of Medical Oncology, Bologna, 40138, Italy|Pres.Ospedal.Spedali Civili Brescia -, Brescia (BS), Italy|Azienda Ospedaliero-Universitaria Careggi, Firenze, 50134, Italy|Irccs Istituto Nazionale Dei Tumori (Int), Milano (MI), 20133, Italy|Azienda Ospedaliero-Universitaria di Modena - Policlinico, Modena, 41124, Italy|Irccs Istituto Nazionale Tumori Fondazione Pascale -, Napoli (NA), Italy|Ospedale Misericordia e Dolce Ist. Toscano Tumori, Az. USL4, Prato, 59100, Italy|Arcispedale S. Maria Nuova Azienda Ospedaliera Di Reggio Emilia, Reggio EMilia, 42123, Italy|Fondazione Policlinico Universitario "Agostino Gemelli", Roma, 00168, Italy|Istituto Regina Elena - IFO, Rome, 00100, Italy|Presidio Sanitario Gradenigo Di Torino, Torino (TO), Italy|Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, 10126, Italy Less <<
NCT03085225 Ovarian Carcinoma ... More >> Soft Tissue Sarcoma Less << Phase 1 Recruiting May 5, 2021 France ... More >> Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Antoine ITALIANO, MD, PhD          Principal Investigator: Antoine ITALIANO, MD, PhD          Sub-Investigator: Anne FLOQUET, MD          Sub-Investigator: Maud TOULMONDE, MD          Centre Léon Bérard Not yet recruiting Lyon, France, 69373 Contact: Medhi BRAHMI, MD          Principal Investigator: Medhi BRAHMI, MD          Institut Gustave Roussy Not yet recruiting Villejuif, France, 94800 Contact: Axel Le Cesne, MD          Principal Investigator: Axel LE CESNE, MD Less <<
NCT04305548 Mesenchymal Chondrosarcoma PHASE2 RECRUITING 2025-12-01 Nuovo Ospedale di Prato, Prato... More >>, Firenze, 59100, Italy|Policlinico Universitario Campus Biomedico, Roma, RM, 00128, Italy|Fondazione del Piemonte per l'Oncologia IRCC Candiolo, Candiolo, Torino, 10060, Italy|Istituto Ortopedico Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors, Bologna, 40136, Italy|Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, 20133, Italy|Ospedale Giaccone, Palermo, Italy|Istituti Fisioterapici Ospitalieri - Ospedale Regina Elena, Roma, 00128, Italy Less <<
NCT05131386 Soft Tissue Sarcoma|Bone Tumor... More >>s|Small Round-cell Sarcomas Less << PHASE2 RECRUITING 2024-07-28 Hospital Universitari Vall d'H... More >>ebrón, Barcelona, Catalu?a, 08035, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Catalu?a, 08041, Spain|Hospital General Universitario Gregorio Mara?ón, Madrid, Comunidad De Madrid, 28009, Spain|Hospital Clínico San Carlos, Madrid, Comunidad De Madrid, 28040, Spain|Hospital Universitario Fundación Jiménez Díaz, Madrid, Comunidad De Madrid, 28040, Spain|Hospital Universitario La Paz, Madrid, Comunidad De Madrid, 28046, Spain|Hospital Universitario de Canarias, Tenerife, Islas Canarias, 38320, Spain Less <<
NCT04394728 Sarcoma COMPLETED 2025-01-20 -
NCT04008238 Soft Tissue Sarcoma Adult|Undi... More >>fferentiated Pleomorphic Sarcoma|Epithelioid Sarcoma|Solitary Fibrous Tumors|Hemangioendothelioma|Desmoplastic Round Cell Tumor|Synovial Sarcoma Less << RECRUITING 2025-01-25 Institut Bergonie, Bordeaux, 3... More >>3076, France Less <<
NCT04535271 Leiomyosarcoma PHASE2 RECRUITING 2024-12-30 Sant P Chawla, Santa Monica, C... More >>alifornia, 90403, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.31mL

0.26mL

0.13mL

6.56mL

1.31mL

0.66mL

13.13mL

2.63mL

1.31mL

References

 

Historical Records

Categories